HistoSonics has completed patient enrollment in a pivitol clinical trial to evaluate its Edison histotripsy system in ...

Researchers have created a new kind of nanoparticle that could make ultrasound-based cancer treatments more effective and safer, while also helping prevent tumors from coming back. The study ...

Researchers have created a new kind of nanoparticle that could make ultrasound-based cancer treatments more effective and safer, while also helping prevent tumors from coming back. The study, ...

Scientists created a new nanoparticle aimed at making ultrasound-based cancer therapy more safe and effective.

The future of non-invasive cancer therapy is bright. Liver tumors can now be destroyed—without radiation, chemotherapy or surgery—thanks to new medical technology known as histotripsy.

The urology ultrasound devices market is projected to grow at a CAGR of 6%, driven by the rising prevalence of urological ...

After FDA approval in late 2023, the non-invasive liver tumor treatment histotripsy has been used at University of Michigan ...

Virginia Tech researchers are developing more precise treatments for pediatric brain cancer using a new class of therapies ...

HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today ...

After publishing early clinical results of its ultrasound-activated brain tumor therapy this year, Alpheus Medical has raised $52 million in venture capital funding to support a new randomized trial.

Uijeongbu Eulji University Hospital introduced a three-dimensional automatic breast cancer ultrasound equipment that ...